Request Deal Involvement
Repligen to acquire bioprocessing analytics portfolio of 908 Devices for $70m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Centerview Partners
legal advisors
Goodwin Procter
financial advisors
Perella Weinberg Partners
legal advisors
Paul Hastings
or
Principals
target
908 DEVICES (BIOPROCESSING ANALYTICS PORTFOLIO)
bidder
REPLIGEN CORPORATION
vendor
908 DEVICES
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite